Skip to main content
HUMASIS CO., LTD. logo

HUMASIS CO., LTD. — Investor Relations & Filings

Ticker · 205470 ISIN · KR7205470008 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2021-12-27 Delisting Announcement
Country KR South Korea
Listing KO 205470

About HUMASIS CO., LTD.

https://www.humasis.com/en/

Humasis Co., Ltd. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) devices, with a primary focus on Point-of-Care Testing (POCT). The company develops and produces a range of rapid diagnostic solutions, including immunodiagnostic kits for the early screening of various diseases, compact instruments for quantitative analysis, and personal health care products. A key operational strength is the in-house development and production of critical bio-materials, such as diagnostic immune antigens, which ensures the consistent performance and accuracy of its products. Humasis aims to provide technologies for precise and rapid disease analysis to support clinical decision-making and promote individual health management.

Recent filings

Filing Released Lang Actions
주권매매거래정지(단일판매공급계약)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for Humasis Co., Ltd. due to a single sales supply contract. It cites specific KOSDAQ market regulations and provides the duration of the suspension. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or financial reports, it falls under the general regulatory filings category.
2021-12-27 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal disclosure of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by Humasis. It details the contract value, the counterparty (Celltrion), the contract period, and the nature of the supply (antigen diagnostic home kits). This type of disclosure is a standard regulatory filing in the Korean market (DART system) regarding material business contracts, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A or share issuance.
2021-12-27 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Correction Report' (정정신고) for a previously disclosed 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details a change in the contract end date due to a delivery schedule extension. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into categories like earnings, dividends, or board changes, it is classified as a general Regulatory Filing (RNS).
2021-12-27 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details a change in the contract end date for a COVID-19 diagnostic kit supply agreement. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into categories like financial reports or board changes, it is classified as a Regulatory Filing (RNS).
2021-12-24 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal disclosure of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by Humasis. It details the contract value, the counterparty (Celltrion), the contract period, and the nature of the goods (antigen diagnostic kits). In the context of Korean regulatory filings (DART), this is a standard material event disclosure regarding a business contract, which falls under the 'Regulatory Filings' (RNS) category as it does not fit into specific categories like M&A, dividends, or share issues.
2021-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given the nature of the announcement as a regulatory disclosure, it fits best under the RNS category.
2021-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.